| Literature DB >> 33936926 |
Chang-Ho Kang1, Jin-Seong Kim1, Hye Min Park1, Seonyoung Kim1, Nam-Soo Paek1.
Abstract
Compounds of the cell walls of heat-killed lactic acid bacteria show immunomodulatory properties which boost immunological systems, and are used ad postbiotics (paraprobiotics). In this study, we used 17 different heat-killed isolates as postbiotics and evaluated their anti-inflammatory potential on the expression of proinflammatory mediators and cellular signaling pathways of murine macrophage, RAW 264.7 cells. Bifidobacterium bifidum MG731 showed the high 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity (90.6%), followed by Bifidobacterium lactis MG741 (59.6%). The Bi. lactis MG741 showed the high ABTS free radical scavenging activity (99.5%), followed by Lactobacillus plantarum MG989 (98.9%), Lactobacillus salivarius MG242 (97.1%), and Bi. bifidum MG731 (96.1%). In addition, Bi. bifidum MG731 showed the lowest nitric oxide production (4.28 µM), followed by B. lactis MG741 (10.80 µM), L. salivarius MG242 (14.60 µM), and L. plantarum MG989 (19.60 µM). The selected strains showed a decreased nitric oxide production via downregulation of inducible nitric oxide synthase and cyclooxygenase 2, which were upregulated via LPS-stimulated RAW 264.7 macrophages. Short-chain fatty acids (SCFA) including acetic, propionic, and butyric acid were produced by four strains. The Bi. bifidum MG731 showed total SCFAs production (4998.6 µg/g), Bi. lactis MG741 (2613.9 µg/g), L. salivarius MG242 (1456.1 µg/g), and L. plantarum MG989 (630.2 µg/g). These results indicated that the various selected strains may possess an anti-inflammatory potential and provide a molecular basis for the development of functional probiotics.Entities:
Keywords: Anti-inflammation; Antioxidant; Probiotics; Short-chain fatty acid
Year: 2021 PMID: 33936926 PMCID: PMC8050147 DOI: 10.1007/s13205-021-02767-y
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.406
Primer sequences of the primers used for reverse transcription-polymerase chain reaction assay
| Gene | Sequence | |
|---|---|---|
| TNF-α | Sense Antisense | 5′-AGCCCACGTCGTAGCAAACCACCAA-3′ 5′-AACACCCATTCCCTTCACAGAGCAAT-3′ |
| iNOS | Sense Antisense | 5′-CCCTTCCGAAGTTTCTGGCAGC-3′ 5′-GGCTGTCAGAGCCTCGTGGCTT-3′ |
| COX-2 | Sense Antisense | 5′-GGAGAGACTATCAAGATAGTGATC-3′ 5′-ATGGTCAGTAGACTTTTACAGCTC-3′ |
| GAPDH | Sense Antisense | 5′-TGAAGGTCGGTGTGAACGGATTTGGC-3′ 5′-CATGTAGGCCATGAGGTCCACCAC-3′ |
TNF-α tumor necrosis factor alpha; iNOS inducible nitric oxide synthase; COX-2 cyclooxygenase 2; GAPDH glyceraldehyde-3-phosphate dehydrogenase
Radical scavenging activity of heat-killed culture samples
| Isolated from | Samples | DPPH radical scavenging (%) | ABTS radical scavenging (%) |
|---|---|---|---|
| Breast milk | 40.9 ± 9.2 | 60.9 ± 2.8 | |
| Infant feces | 51.9 ± 3.7 | 75.2 ± 0.5 | |
| 50.2 ± 1.7 | 76.6 ± 0.1 | ||
| 90.6 ± 2.3 | 96.1 ± 0.4 | ||
| 59.6 ± 2.1 | 99.5 ± 0.7 | ||
| Human | 31.7 ± 2.9 | 62.2 ± 0.3 | |
| Human vagina | 56.9 ± 6.0 | 97.1 ± 0.4 | |
| 22.4 ± 5.6 | 48.0 ± 1.8 | ||
| 59.4 ± 3.8 | 98.9 ± 0.5 | ||
| Fermented food | 19.5 ± 5.0 | 28.2 ± 0.9 | |
| 19.4 ± 11.5 | 29.3 ± 0.7 | ||
| 42.5 ± 10.5 | 49.2 ± 0.6 | ||
| 51.7 ± 2.8 | 76.1 ± 8.3 | ||
| 45.3 ± 4.2 | 84.0 ± 0.6 | ||
| 18.4 ± 1.8 | 47.8 ± 1.6 | ||
| 17.8 ± 1.6 | 27.1 ± 0.4 | ||
| 55.9 ± 4.0 | 87.4 ± 1.4 | ||
| Mixture | 44.1 ± 0.8 | 73.6 ± 0.3 | |
DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
Fig. 1Inhibition of nitric oxide production in LPS-stimulated RAW264.7 cells treated with 18 samples (17 strains and mixture sample). The results are presented as mean ± standard deviation of three independent experiments (n = 3). ***P < .001, versus LPS
Fig. 2RT-PCR analysis of the mRNA expression of (a) TNF-α, (b) iNOS, and (C) COX-2. Values shown are mean ± standard deviation of three independent experiments. *P < .05; **P < .01; ***P < .001, versus LPS
Short-chain fatty acid profile of 18 samples
| Samples | AA (μg/g) | PA (μg/g) | BA (μg/g) | Total SCFA (μg/g) |
|---|---|---|---|---|
| 1455.0 ± 6.8 | 0.95 ± 1.36 | 0.15 ± 0.05 | 1456.1 ± 8.2 | |
| 867.0 ± 4.3 | 0.45 ± 0.06 | 0.05 ± 0.02 | 867.5 ± 4.4 | |
| 802.0 ± 4.9 | 1.55 ± 0.27 | 2.05 ± 0.17 | 805.6 ± 5.3 | |
| 1354.0 ± 9.4 | 1.15 ± 0.12 | 0.20 ± 0.08 | 1355.4 ± 9.6 | |
| 1444.0 ± 9.2 | 0.85 ± 0.05 | 0.05 ± 0.02 | 1444.9 ± 9.3 | |
| 316.0 ± 3.2 | 0.50 ± 0.01 | 0.65 ± 0.03 | 317.2 ± 3.2 | |
| 1153.0 ± 9.3 | 0.95 ± 0.15 | 0.20 ± 0.01 | 1154.2 ± 9.5 | |
| 3902.0 ± 14.9 | 0.60 ± 0.23 | 0.65 ± 0.03 | 3903.3 ± 15.2 | |
| 356.0 ± 1.2 | 0.30 ± 0.07 | 0.45 ± 0.01 | 356.8 ± 1.3 | |
| 4995.0 ± 22.6 | 1.55 ± 0.26 | 2.00 ± 0.35 | 4998.6 ± 23.2 | |
| 2610.0 ± 19.2 | 1.83 ± 0.03 | 2.05 ± 0.21 | 2613.9 ± 19.4 | |
| 1294.0 ± 8.7 | 0.50 ± 0.02 | 0.00 ± 0.00 | 1294.5 ± 8.7 | |
| 628.4 ± 2.7 | 0.88 ± 0.07 | 0.93 ± 0.18 | 630.2 ± 3.0 | |
| 428.0 ± 1.8 | 0.30 ± 0.02 | 0.25 ± 0.02 | 428.6 ± 1.8 | |
| 1253.4 ± 4.3 | 1.03 ± 0.09 | 0.48 ± 0.08 | 1254.9 ± 4.5 | |
| 971.7 ± 2.9 | 0.93 ± 0.04 | 0.23 ± 0.03 | 972.9 ± 3.0 | |
| 1489.0 ± 2.6 | 19.90 ± 0.40 | 80.70 ± 3.63 | 1589.6 ± 6.6 | |
| Mixture | 871.7 ± 2.7 | 3.60 ± 0.56 | 4.68 ± 0.34 | 880.0 ± 3.6 |
AA acetic acid; PA propionic acid; BA butyric acid
Data are presented as mean ± standard deviation (n = 3)